Biote's Business Segments

Biote Corp is a globally renowned biotechnology company headquartered in the United States. It was founded in 1995 with the aim of revolutionizing the healthcare industry through cutting-edge biotechnological innovations. The company is committed to improving human health and enhancing the quality of life by developing and delivering innovative therapeutics and diagnostic solutions.

Biote Corp's core emphasis lies in the discovery, development, and commercialization of novel drugs, therapies, and diagnostic tools for various complex diseases and medical conditions. The company's robust research and development pipeline encompass a wide range of therapeutic areas, including oncology, rare diseases, autoimmune disorders, cardiovascular diseases, infectious diseases, and neurological disorders.

The company's team of talented scientists, researchers, and medical professionals work tirelessly to identify new target molecules, conduct pre-clinical studies, and engage in rigorous clinical trials to demonstrate the safety and efficacy of their potential therapeutic candidates. Biotechnological techniques such as genetic engineering, protein engineering, and molecular biology form the basis of their drug development process.

Biote Corp has a state-of-the-art manufacturing facility equipped with advanced technologies and adheres to strict quality assurance standards to ensure the production of safe and reliable drugs. The company also maintains strong collaborations with academic institutions, government agencies, and other biotech companies to promote scientific knowledge-sharing and drive innovation.

Not only does Biote Corp focus on therapeutic development, but it also invests heavily in diagnostics. The company's diagnostic division works diligently to develop and commercialize diagnostic tools that aid in the early detection, prognosis, and monitoring of various diseases. These diagnostic tools include molecular assays, genetic tests, and imaging technologies, which contribute to personalized medicine and precision healthcare.

Biote Corp has a robust global presence and collaborates with healthcare providers, research institutions, and pharmaceutical companies worldwide to ensure global access to its innovative products. The company actively participates in scientific conferences, trade shows, and healthcare events to showcase its products and build relationships with key stakeholders in the industry.

In addition to its commitment to scientific advancement, Biote Corp also places a strong emphasis on corporate social responsibility. The company engages in various philanthropic activities, supports community healthcare programs, and advocates for sustainable and ethical practices.

Overall, Biote Corp stands as a highly reputable biotechnology company that strives for scientific excellence, innovative drug development, and the betterment of global healthcare. Its unwavering dedication to advancing the frontiers of biotechnology and improving patient outcomes solidifies its position as a leading player in the industry.

The Company operates as a single operating segment. The Chief Executive Officer, serving as the Chief Operating Decision Maker (CODM), reviews financial information on a consolidated basis and uses consolidated net income (loss) to allocate resources and assess performance. The CODM does not regularly review financial information by individual revenue streams, sales channels, or geographic regions. The Company generates substantially all of its revenue from long-term service agreements and sales of Biote-branded dietary supplements. Total U.S. revenues were $191.2 million and $196.2 million for the years ended December 31, 2025, and 2024, respectively. The Company's long-lived tangible assets and operating lease right-of-use assets are located in the U.S.